DUPILUMAB IMPROVED ASTHMA CONTROL ACROSS BASELINE IMMUNOGLOBULIN E LEVELS: LIBERTY ASTHMA QUEST STUDY

被引:1
|
作者
Carr, W.
Corren, J.
Rice, M.
Deniz, Y.
Rowe, P.
Teper, A.
Khan, A.
Kamat, S.
机构
关键词
D O I
10.1016/j.anai.2019.08.289
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
P223
引用
收藏
页码:S39 / S40
页数:3
相关论文
共 50 条
  • [31] Dupilumab Reduced Oral Corticosteroid Use in Patients with OCS-Dependent Severe Asthma Consistently Across Baseline Disease Characteristics in the Phase 3 LIBERTY ASTHMA VENTURE Study
    Castro, M.
    Hanania, N. A.
    Daizadeh, N.
    Ortiz, B.
    Pandit-Abid, N.
    Deniz, Y.
    Rowe, P.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 201
  • [32] Dupilumab reduces exacerbations and improves lung function in uncontrolled, moderate-to-severe asthma patients across prior historical exacerbation subgroups in the phase 3 LIBERTY ASTHMA QUEST study
    Ford, L.
    Corren, J.
    Kuna, P.
    Dong, Q.
    Staudinger, H.
    Maroni, J.
    Rowe, P.
    Amin, N.
    Pirozzi, G.
    Ruddy, M.
    Akinlade, B.
    Graham, N. M. H.
    Teper, A.
    ALLERGY, 2018, 73 : 464 - 465
  • [33] EFFICACY OF DUPILUMAB IN CHILDREN WITH UNCONTROLLED TYPE 2 ASTHMA RECEIVING HIGH/MEDIUM DOSES OF INHALED CORTICOSTEROIDS AT BASELINE: THE LIBERTY ASTHMA VOYAGE STUDY
    Maspero, Jorge F.
    Antila, Martti
    Jain, Neal
    Deschildre, Antoine
    Bacharier, Leonard B.
    Altincatal, Arman
    Laws, Elizabeth
    Akinlade, Bolanle
    Siddiqui, Shahid
    Jacob-Nara, Juby A.
    Deniz, Yamo
    Rowe, Paul J.
    Lederer, David J.
    Hardin, Megan
    CHEST, 2022, 162 (04) : 1945A - 1947A
  • [34] Cost-effectiveness analysis of dupilumab among patients with uncontrolled severe asthma using LIBERTY ASTHMA QUEST Korean data
    Oh, Sung-Hee
    Rhee, Chin Kook
    Bae, Eun Jin
    Ku, Hyemin
    HEALTH ECONOMICS REVIEW, 2024, 14 (01):
  • [35] Dupilumab improves asthma-related patient reported outcomes in asthma patients with chronic rhinosinusitis or nasal polyposis (CRS/NP) in LIBERTY ASTHMA QUEST
    Corren, Jonathan
    Castro, Mario
    Maspero, Jorge F.
    Santiago, Antonio L. Valero
    Kuna, Piotr
    Guillonneau, Sophie
    Dong, Qunming
    Taniou, Christine
    Staudinger, Heribert
    Chao, Jingdong
    Amin, Nikhil
    Pirozzi, Gianluca
    Ruddy, Marcella
    Akinlade, Bolanle
    Graham, Neil M. H.
    Teper, Ariel
    Khan, Asif
    EUROPEAN RESPIRATORY JOURNAL, 2018, 52
  • [36] Baseline FeNO as a Prognostic Biomarker for Subsequent Severe Asthma Exacerbations in Patients With Uncontrolled, Moderate-to-Severe Asthma Receiving Placebo in the LIBERTY ASTHMA QUEST Study
    Busse, William
    Pavord, Ian
    Wenzel, Sally
    Bateman, Eric
    Casale, Thomas
    FitzGerald, J.
    Rice, Megan
    Deniz, Yamo
    Patel, Naimish
    Harel, Sivan
    Rowe, Paul
    Graham, Neil
    O'Riordan, Thomas
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2020, 145 (02) : AB21 - AB21
  • [37] Impact of severe exacerbations on lung function in dupilumab-treated patients: LIBERTY ASTHMA QUEST
    Papi, Alberto
    Chapman, Kenneth R.
    Castro, Mario
    Jackson, Daniel J.
    Daizadeh, Nadia
    Pandit-Abid, Nami
    Deniz, Yamo
    Rowe, Paul
    Ortiz, Benjamin
    EUROPEAN RESPIRATORY JOURNAL, 2021, 58
  • [38] Dupilumab Reduced Oral Corticosteroid (OCS) Use in Patients with OCS-Dependent, Severe Asthma Consistently Across Baseline Demographic Characteristics in the Phase 3 LIBERTY ASTHMA VENTURE Study
    Maspero, J. F.
    Ford, L. B.
    Daizadeh, N.
    Pandit-Abid, N.
    Ortiz, B.
    Rowe, P.
    Deniz, Y.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 201
  • [39] DUPILUMAB DEMONSTRATES RAPID AND SUSTAINED IMPROVEMENTS IN DAILY ASTHMA-RELATED SYMPTOMS IN PATIENTS WITH UNCONTROLLED, MODERATE-TO-SEVERE ASTHMA: DATA FROM THE LIBERTY ASTHMA QUEST STUDY
    Douglass, Jo
    Langton, David
    Corren, Jonathan
    Castro, Mario
    Guillonneau, Sophie
    Chao, Jingdong
    Amin, Nikhil
    Graham, Neil M. H.
    Teper, Ariel
    Khan, Asif
    INTERNAL MEDICINE JOURNAL, 2018, 48 : 22 - 23
  • [40] Dupilumab Improved Morning and Evening Daily Asthma Symptoms in Patients with Oral-Corticosteroid-Dependent Severe Asthma in the Phase 3 LIBERTY ASTHMA VENTURE Study
    Sher, L.
    Rabe, K. F.
    Wolfe, R. N.
    Quirce, S.
    Rice, M. S.
    Rowe, P.
    Lu, Y.
    Kamat, S.
    Amin, N.
    Graham, N. M. H.
    Teper, A.
    Khan, A.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2019, 199